Bonilla, MD, MSEd, discusses 5-year data from the phase 3 CheckMate 577 trial, presented at the 2025 ASCO Annual Meeting.

OSWEGO – The Center for Gastroenterology & Metabolic Diseases of Oswego Health Medical Practice is now offering access to an innovative laboratory test — TissueCypher — that can help ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

The Center for Gastroenterology & Metabolic Diseases of Oswego Health Medical Practice is now offering access to an innovative laboratory test — TissueCypher — that can help predict ...

Cancer persists as a leading cause of mortality worldwide, underscoring the urgent need to decipher its molecular complexity for improved detection, ...

In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in ...